Bangert, Christine http://orcid.org/0000-0003-3392-6590
Alkon, Natalia http://orcid.org/0000-0002-0336-5318
Chennareddy, Sumanth
Arnoldner, Tamara
Levine, Jasmine P.
Pilz, Magdalena
Medjimorec, Marco A.
Ruggiero, John
Cohenour, Emry R.
Jonak, Constanze http://orcid.org/0000-0002-2347-436X
Damsky, William http://orcid.org/0000-0003-0975-4071
Griss, Johannes http://orcid.org/0000-0003-2206-9511
Brunner, Patrick M. http://orcid.org/0000-0002-3488-3345
Article History
Received: 3 July 2023
Accepted: 1 March 2024
First Online: 2 April 2024
Competing interests
: C.B. has received personal fees from ALK, Mylan, LEO Pharma, Pfizer, Sanofi Genzyme, Eli Lilly, Novartis, Almirall and AbbVie. C.B. is an investigator for Novartis, Sanofi, Abbvie, Elli Lilly, LEO Pharma and Galderma. C.J. has received personal fees from LEO Pharma, Pfizer, Recordati Rare Diseases, Eli Lilly and Company, Novartis, Takeda, AbbVie, Janssen, UCB, Sandoz, Kyowa Kirin, Bristol Myers Squibb, and Almirall. C.J. is an investigator for Eli Lilly and Company, Novartis, Innate Pharma, and 4SC (grant paid to her institution). W.D. has received personal fees from Pfizer, Incite, Eli Lilly, TWI Biotechnology, Fresenius Kabi, Epiarx Diagnostics, and Boehringer Ingelheim. W.D. has received research support from Pfizer, Advanced Cell Diagnostics/Bio-techne, Abbvie, Bristol Myers Squibb, and Incite. W.D. receives licensing fees from EMD/Millipore/Sigma. JG has received personal fees from AbbVie and Novartis. P.M.B. has received personal fees from LEO Pharma, Pfizer, Sanofi Genzyme, Eli Lilly, Novartis, Celgene, UCB Pharma, Biotest, Boehringer Ingelheim, AbbVie, Amgen, Arena Pharmaceuticals, GSK, BMS, Almirall and Regeneron. PMB has received research support from Pfizer. N.A., S.C., T.A., J.P.L., M.P., M.A.M., J.R. and E.R.C. declare no competing interests.